Food and Drug Administration | Government Grants

Food and Drug Administration Grants

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)

Food and Drug Administration

The purpose of this funding opportunity announcement (FOA) is to support clinical studies of products that address unmet needs in rare diseases or conditions or provide highly significant...more

Posted On - 2018-10-23

Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)

Food and Drug Administration

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare...more

Posted On - 2018-10-12

State and Territory Produce Safety Implementation Program Expansion for Entrance into Competition B of PAR-16-137 (U18)

Food and Drug Administration

This program expansion FOA provides a mechanism for organizations receiving only Competition A funding under PAR-16-137 to apply for Competition B funding. Only those states/territories currently...more

Posted On - 2018-10-09

Request for Information (RFI): FDA Standard Core Clinical Outcome Assessments and Endpoints

Food and Drug Administration

Purpose FDA is seeking information submissions from the public. Information is being solicited to inform planned work to promote development of publicly available standard core sets of Clinical...more

Posted On - 2018-07-31

Minor Use Minor Species Development of Drugs (R01)

Food and Drug Administration

The Food & Drug Administration’s (FDA) Center for Veterinary Medicine’s (CVM) Office of Minor Use & Minor Species Animal Drug Development (OMUMS) was created after “The...more

Posted On - 2018-06-12

Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01)

Food and Drug Administration

The Cooperative Agreement will build upon the extensive experience of an institution with well-established and globally recognized collaboration with inspectorates of National Regulatory Authorities...more

Posted On - 2018-06-11

Development of a virtual bioequivalence trial simulation platform that integrates population pharmacokinetic modeling algorithms into physiologically-based pharmacokinetic models (U01)

Food and Drug Administration

Background Mechanism-based physiologically based pharmacokinetic (PBPK) models have been proven to be powerful tools in the generic drug development process and bioequivalence assessment. Major...more

Posted On - 2018-05-23

People Building Stronger Communities

Quality of Life Crimes: Legal System Fails to Make Reforms for Homelessness

Mindfulness Eases Stress, Promotes Wellbeing among Children

Virginia Governor Speaks About Job Creation, Economic Development At Danville

The Civic Engagement Distinguished Lecture

Teaching Kids about Homelessness in a Meaningful Way

A Second Look at Kinship Care

Alcohol Justice to Release Report on State of Public Transit Alcohol Advertising

Mississippi Rural Physicians Scholarship Program

Innovation Economics and Crowdfunding

Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)

Food and Drug Administration

RESEARCH OBJECTIVES The FDA Center for Drug Evaluation and Research seeks to support efforts to research, identify key issues, and convene appropriate subject matter experts to help advance...more

Posted On - 2018-05-17

Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)

Food and Drug Administration

The Cooperative Agreement announced in this FOA represents the continuation and further refinement as well as expansion of well-established collaborations between WHO and FDA, through OIP, in support...more

Posted On - 2018-04-25

Next 9 Announcements >>